Literature DB >> 10855946

Induction of apoptosis in mouse brain capillary endothelial cells by cyclosporin A and tacrolimus.

S Kochi1, H Takanaga, H Matsuo, H Ohtani, M Naito, T Tsuruo, Y Sawada.   

Abstract

Although cyclosporin A and tacrolimus are used clinically as potent immunosuppressants, there have been reports of neurotoxicity and encephalopathy. A possible mechanism is that these drugs damage the blood-brain barrier (BBB), inducing dysfunction and increased permeability, and are then able to enter the brain. We studied the cytotoxicity of cyclosporin A and tacrolimus, focused on apoptosis induction, using an immortalized cell line established from BALB/c mouse cerebral microvessel endothelial cells (MBEC4). We found that these two drugs induced cell shrinkage, chromatin condensation and DNA fragmentation, which are characteristics of apoptosis. Our data suggest that the induction of apoptosis on the brain capillary endothelial cells may be at least partly involved in the occurrence of immunosuppressant-induced encephalopathy.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10855946     DOI: 10.1016/s0024-3205(00)00554-3

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


  15 in total

1.  Tacrolimus-related encephalopathy following allogeneic stem cell transplantation in children.

Authors:  Takahisa Kanekiyo; Junichi Hara; Yoshiko Matsuda-Hashii; Hiroyuki Fujisaki; Sadao Tokimasa; Akihisa Sawada; Keiko Kubota; Kuriko Shimono; Katsumi Imai; Keiichi Ozono
Journal:  Int J Hematol       Date:  2005-04       Impact factor: 2.490

2.  Achieving stable human stem cell engraftment and survival in the CNS: is the future of regenerative medicine immunodeficient?

Authors:  Aileen J Anderson; Daniel L Haus; Mitra J Hooshmand; Harvey Perez; Christopher J Sontag; Brian J Cummings
Journal:  Regen Med       Date:  2011-05       Impact factor: 3.806

Review 3.  Angiogenic factors and inflammation in steroid-refractory acute graft-vs-host disease.

Authors:  Shernan G Holtan; Mukta Arora
Journal:  Transl Res       Date:  2015-06-09       Impact factor: 7.012

Review 4.  Neurotoxicology of the brain barrier system: new implications.

Authors:  W Zheng
Journal:  J Toxicol Clin Toxicol       Date:  2001

5.  Posterior reversible encephalopathy syndrome: do predisposing risk factors make a difference in MRI appearance?

Authors:  Christina Mueller-Mang; Thomas Mang; Agnes Pirker; Katharina Klein; Christine Prchla; Daniela Prayer
Journal:  Neuroradiology       Date:  2009-02-21       Impact factor: 2.804

6.  The immunophilin-ligands FK506 and V-10,367 mediate neuroprotection by the heat shock response.

Authors:  Alexa Klettner; Thomas Herdegen
Journal:  Br J Pharmacol       Date:  2003-03       Impact factor: 8.739

7.  The immunophilin ligands cyclosporin A and FK506 suppress prostate cancer cell growth by androgen receptor-dependent and -independent mechanisms.

Authors:  Sumudra Periyasamy; Manya Warrier; Manoranjani P M Tillekeratne; Weinian Shou; Edwin R Sanchez
Journal:  Endocrinology       Date:  2007-07-05       Impact factor: 4.736

Review 8.  Posterior Reversible Encephalopathy Syndrome After Transplantation: a Review.

Authors:  Sheng Chen; Jun Hu; Liang Xu; Dixon Brandon; Jun Yu; Jianmin Zhang
Journal:  Mol Neurobiol       Date:  2015-12-14       Impact factor: 5.590

Review 9.  Tacrolimus: a further update of its use in the management of organ transplantation.

Authors:  Lesley J Scott; Kate McKeage; Susan J Keam; Greg L Plosker
Journal:  Drugs       Date:  2003       Impact factor: 9.546

Review 10.  Identifying New Substrates and Functions for an Old Enzyme: Calcineurin.

Authors:  Jagoree Roy; Martha S Cyert
Journal:  Cold Spring Harb Perspect Biol       Date:  2020-03-02       Impact factor: 10.005

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.